U.S. Markets closed

Biogen Surpassed Estimates in Q3 2018, Reports Strong Growth

Mike Benson
Biogen Surpassed Estimates in Q3 2018, Reports Strong Growth

Biogen (BIIB), a leading biotechnology company, released its third-quarter earnings on October 23. Biogen surpassed Wall Street analysts’ estimates for EPS and revenues during the quarter. Biogen reported non-GAAP diluted EPS of $7.40 on revenues of ~$3.44 billion.